Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04031729
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Nonalcoholic Fatty Liver
Nonalcoholic Steatohepatitis
Interventions
DRUG:
Aspirin 81 mg
DRUG:
Placebo oral tablet
Sponsor
Massachusetts General Hospital